Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance. Maltezou HC, Hatziantoniou S, Theodoridou K, Vasileiou K, et al. Vaccine 2023 Feb 27:S0264-410X(23)00221-9. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Maltezou HC, Hatziantoniou S, Theodoridou K, Vasileiou K, et al. Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance. Vaccine 2023 Feb 27:S0264-410X(23)00221-9. doi: 10.1016/j.vaccine.2023.
PMID: 36872145